chr2-200893289-C-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001369441.2(NIF3L1):āc.480C>Gā(p.Asn160Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000515 in 1,590,442 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001369441.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
NIF3L1 | NM_001369441.2 | c.480C>G | p.Asn160Lys | missense_variant | 3/7 | ENST00000409020.6 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
NIF3L1 | ENST00000409020.6 | c.480C>G | p.Asn160Lys | missense_variant | 3/7 | 5 | NM_001369441.2 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000434 AC: 66AN: 152190Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000216 AC: 51AN: 235698Hom.: 0 AF XY: 0.000218 AC XY: 28AN XY: 128644
GnomAD4 exome AF: 0.000524 AC: 753AN: 1438252Hom.: 0 Cov.: 31 AF XY: 0.000498 AC XY: 356AN XY: 714416
GnomAD4 genome AF: 0.000434 AC: 66AN: 152190Hom.: 0 Cov.: 32 AF XY: 0.000296 AC XY: 22AN XY: 74346
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 13, 2022 | The c.480C>G (p.N160K) alteration is located in exon 3 (coding exon 2) of the NIF3L1 gene. This alteration results from a C to G substitution at nucleotide position 480, causing the asparagine (N) at amino acid position 160 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at